Updated: January 23, 2026
Qsymia Side Effects: What to Expect and When to Call Your Doctor
Author
Peter Daggett

Summarize with AI
Pins-and-needles, dry mouth, and dizziness are common Qsymia side effects. Learn which are normal, which require a call to your doctor, and how to manage them.
Qsymia (phentermine/topiramate extended-release) is effective for weight management, but like any medication, it comes with a side effect profile worth understanding before you start. Knowing what's normal, what's manageable, and what requires a call to your doctor can make your experience with Qsymia safer and less stressful.
Most Common Side Effects of Qsymia
In controlled clinical trials in adults, the following side effects occurred in at least 5% of Qsymia patients and at least 1.5 times more frequently than in placebo patients:
Paresthesia ("pins and needles"): A tingling or numbness sensation in the hands, feet, or face. This is the most commonly reported side effect of Qsymia. It's caused by topiramate's effect on carbonic anhydrase and is usually mild and temporary.
Dizziness: Lightheadedness, especially when standing up quickly. Often improves after the first few weeks.
Dysgeusia (altered taste): Food may taste different or less appealing than usual. This can actually support weight loss by reducing the pleasure of eating.
Insomnia: Difficulty sleeping, especially if Qsymia is taken late in the day. Always take Qsymia in the morning to minimize sleep disruption.
Constipation: Reduced bowel frequency is common. Increasing water and fiber intake typically helps.
Dry mouth: A frequent complaint that usually improves over time. Staying well-hydrated helps.
Side Effects in Adolescents (Ages 12–17)
In clinical trials for pediatric patients aged 12–17, the most commonly reported side effects (occurring in at least 4% of patients and more than placebo) were:
Depression
Dizziness
Joint pain (arthralgia)
Fever (pyrexia)
Flu-like symptoms (influenza)
Importantly, Qsymia may slow height growth in adolescents. Pediatric prescribers should monitor height velocity throughout treatment.
Serious Side Effects: When to Call Your Doctor Immediately
Some Qsymia side effects are serious and require prompt medical attention:
Eye pain or vision changes: Stop Qsymia and seek care immediately if you develop sudden eye pain, redness, or vision changes. Topiramate can cause acute myopia and secondary angle-closure glaucoma.
Suicidal thoughts or behavior: Topiramate carries a risk of suicidal thoughts, especially in the first weeks of treatment. Call 911 or go to an emergency room immediately. If not in crisis, call the 988 Suicide and Crisis Lifeline.
Severe mood changes or depression: Contact your doctor if you notice worsening depression, unusual mood swings, or significant behavioral changes.
Decreased sweating + overheating: Topiramate can reduce sweating (oligohidrosis), raising the risk of heat-related illness. If you notice you're not sweating normally during exercise in hot weather, take it seriously and contact your provider.
Kidney stones: Topiramate can increase kidney stone risk by inhibiting carbonic anhydrase. Symptoms include sudden back or flank pain, blood in urine, and painful urination.
Fast or irregular heartbeat: Phentermine can increase heart rate. Significant palpitations or an irregular heartbeat should be reported to your doctor.
Severe skin reactions: If you develop a rash, blistering, or peeling skin, stop Qsymia and seek medical attention. Stevens-Johnson syndrome has been reported rarely with topiramate use.
Boxed Warnings: Fetal Harm
Qsymia carries a boxed warning for fetal harm. Topiramate can cause cleft lip and/or cleft palate and small-for-gestational-age outcomes if taken during pregnancy, especially in the first trimester. If you become pregnant while taking Qsymia, stop the medication immediately and contact your healthcare provider and the Qsymia Pregnancy Surveillance Program at 1-888-998-4887.
Important Safety Note: Do Not Stop Abruptly
Do not stop the highest dose of Qsymia (15/92 mg) abruptly. The topiramate component can lower the seizure threshold if stopped suddenly. Taper by taking 15/92 mg every other day for at least one week before discontinuing completely.
For a complete guide on Qsymia drug interactions, see our article Qsymia Drug Interactions: What to Avoid and What to Tell Your Doctor. For tips on finding Qsymia in stock, visit medfinder.com.
Frequently Asked Questions
The most common Qsymia side effects in adults (occurring in 5%+ of patients) are: paresthesia (pins-and-needles sensations), dizziness, dysgeusia (altered taste), insomnia, constipation, and dry mouth. These are generally mild and tend to improve after the first few weeks of treatment.
Paresthesia (tingling or numbness in the hands, feet, or face) is the most common Qsymia side effect and is generally harmless. It's caused by topiramate's inhibition of carbonic anhydrase. If the tingling is severe or spreads to new areas, mention it to your provider—but for most patients, it diminishes as the body adjusts.
Yes. Topiramate, an ingredient in Qsymia, can increase the risk of suicidal thoughts or behavior, depression, and anxiety. This risk is highest in the first weeks of treatment. If you or a loved one notice worsening depression or unusual mood changes, contact your provider immediately. In a crisis, call or text 988 (Suicide and Crisis Lifeline).
Stop Qsymia and seek immediate care if you experience: sudden eye pain or vision changes (signs of glaucoma), thoughts of self-harm or suicide, a rash or skin blistering, or severe allergic reaction symptoms (swelling of face/throat, trouble breathing). Call your doctor promptly for: significant mood changes, persistent memory or cognitive problems, decreased sweating with overheating, or signs of kidney stones.
No. Qsymia should not be used during breastfeeding. Both phentermine and topiramate may pass into breast milk. The safety of Qsymia for nursing infants has not been established, and weight loss while breastfeeding may not be appropriate. Discuss alternative weight management strategies with your provider.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Qsymia also looked for:
More about Qsymia
36,324 have already found their meds with Medfinder.
Start your search today.





